The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study

European Journal of Pharmacology

Volumn 626, Issue 2-3, 2010, Pages 171-178

  Bromek, Ewa ^a   Haduch, Anna ^a   Daniel, Władysława A ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

cDNA expressed CYP isoform; Cytochrome P450; Dopamine; Rat brain microsome; Rat brain structure; Tyramine hydroxylation

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 1A1; CYTOCHROME P450 2B1; CYTOCHROME P450 2C; CYTOCHROME P450 2C11; CYTOCHROME P450 2D; CYTOCHROME P450 2D1; CYTOCHROME P450 2E1; DOPAMINE; QUININE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MICROSOME; BRAIN STEM; CATALYSIS; CEREBELLUM; CONTROLLED STUDY; DOPAMINE METABOLISM; ENZYME KINETICS; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; HYDROXYLATION; IN VITRO STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SUBSTANTIA NIGRA;

ANIMALS; BIOCATALYSIS; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; DOPAMINE; ETHANOLAMINES; HUMANS; HYDROXYLATION; ISOENZYMES; MALE; MICROSOMES; QUININE; RATS; RATS, WISTAR; TYRAMINE;

EID: 70749145658     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.062     Document Type: Article

References (36)

1. Berry M.D. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J. Neurochem. 90 (2004) 257-271
2. Bertilsson L., Alm C., De Las Carreras C., Widen J., Edman G., and Schalling D. Debrisoquine hydroxylation polymorphism and personality. Lancet 1 (1989) 555
3. Boobis A.R., Sesardic D., Murray B.P., Edwards R.J., Singleton A.M., Rich K.J., Murray S., de la Torres R., Seguras J., Pelkonen O., Pasanen M., Kobayashi S., Zhi-Guang T., and Davies D.S. Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica 20 (1990) 1139-1161
4. Coleman T., Spellman E.F., Rostami-Hodjegan A., Lennard M.S., and Tucker G.T. The 1′-hydroxylation of rac-bufuralol by rat brain microsomes. Drug Metab. Dispos. 28 (2000) 1094-1099
5. Daniel W.A. Mechanisms of cellular distribution of psychotropic drugs. Significance of drug action and interactions. Prog. Neuropsychopharmacol. Biol. Psychiatr. 27 (2003) 65-73
6. Dorado P., Peñas-Lledo E.M., and Llerena A. CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits. Pharmacogenomics 8 (2007) 1597-1608
7. Funae Y., Kishimoto W., Cho T., Niwa T., and Hiroi T. CYP2D in the brain. Drug Metab. Pharmacokin. 18 (2003) 337-349
8. Gonzáles I., Peñas-Lledo E.M., Pérez B., Dorado P., Alvarez M., and Llerena A. Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers. Pharmacogenomics 9 (2008) 833-840
9. Hiroi T., Imaoka S., Chow T., and Funae Y. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR. Biochim. Biophys. Acta 1380 (1998) 305-312
10. Hiroi T., Imaoka S., and Funae Y. Dopamine formation from tyramine by CYP2D6. Biochem. Biophys. Res. Commun. 249 (1998) 838-843
11. Hiroi T., Kishimoto W., Chow T., Imaoka S., Igarashi T., and Funae Y. Progesterone oxidation by cytochrome P450 2D isoforms in the brain. Endocrinology 142 (2001) 3901-3908
12. Hiroi T., Chow T., Imaoka S., and Funae Y. Catalytic specificity of CYP2D isoforms in rat and human. Drug Metab. Dispos. 30 (2002) 970-976
13. Kishimoto W., Hiroi T., Shiraishi M., Osada M., Imaoka S., Kominami S., Igarashi T., and Funae Y. Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain. Endocrinology 145 (2004) 699-705
14. Kobayashi K., Urashima K., Shimada N., and Chiba K. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem. Pharmacol. 63 (2002) 889-896
15. Komori M. A novel P450 expressed at the high level in rat brain. Biochem. Biophys. Res. Commun. 196 (1993) 721-728
16. Kuczeński R.T., and Mandell A.J. Regulatory properties of soluble and particulate rat brain tyrosine hydroxylase. J. Biol. Chem. 247 (1972) 3114-3122
17. Llerena A., Edman G., Cobaleda J., Benitez J., Schalling D., and Bertilsson L. Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiatr. Scand. 87 (1993) 23-28
18. Mann A., Miksys S., Lee A., Mash D.C., and Tyndale R.F. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology 55 (2008) 1147-1155
19. Miksys S.L., and Tyndale R.F. Drug-metabolizing cytochrome P450s in the brain. J. Psychiatr. Neurosci. 27 (2002) 406-415
20. Miksys S., and Tyndale R.F. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab. Rev. 36 (2004) 313-333
21. Miksys S., Rao Y., Sellers E.M., Kwan M., Mendis D., and Tyndale R.F. Regional and cellular distribution of CYP2D subfamily members in rat brain. Xenobiotica 30 (2000) 547-564
22. Moor M., Honegger U.E., and Wiesmann U.N. Organspecific, qualitative changes in the phospholipid composition of rats after chronic administration of the antidepressant drug desipramine. Biochem. Pharmacol. 37 (1988) 2035-2039
23. Niwa T., Hiroi T., Tsuzuki D., Yamamoto S., Narimatsu S., Fukuda T., Azuma J., and Funae Y. Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6. Mol. Brain Res. 129 (2004) 117-123
24. Norris P.J., Hardwick J.P., and Emson P.C. Regional distribution of cytochrome P450 2D1 in the rat central nervous system. J. Comp. Neurol. 366 (1996) 244-258
25. Oldendorf W.H. Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection. Am. J. Physiol. 221 (1971) 1629-1639
26. Riedl A.G., Watts P.M., Edwards R.J., Schulz-Utermoehl T., Boobis A.R., Jenner P., and Marsden C.D. Expression and localization of CYP2D enzymes in rat basal ganglia. Brain Res. 822 (1999) 175-191
27. Schulz-Utermoehl T., Bennett A.J., Ellis S.W., Tucker G.T., Boobis A.R., and Edwards R.J. Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression. Pharmacogenetics 9 (1999) 357-366
28. Siegle I., Frotz P., Eckhardt K., Zanger U.M., and Eichelbaum M. Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 11 (2001) 237-245
29. Strobel H.W., Thompson C.M., and Antonovic L. Cytochromes P450 in Brain: Function and Significance. Curr. Drug Metab. 2 (2001) 199-214
30. Thompson C.M., Capdevila J.H., and Strobel H.W. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J. Pharmacol. Exp. Ther. 294 (2000) 1120-1130
31. Tyndale R.F., Li Y., Li N.-Y., Messina E., Miksys S., and Sellers E.M. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan. Drug Metab. Dispos. 27 (1999) 924-930
32. Voirol P., Jonzier-Perey M., Porchet F., Reymond M.J., Janzer R.C., Bouras C., Strobel H.W., Kosel M., Eap C.B., and Baumann P. Cytochrome P-450 activities in human and rat brain microsomes. Brain Res. 855 (2000) 235-243
33. Wan J., Imaoka S., Chow T., Hiroi T., Yabusaki Y., and Funae Y. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity. Arch. Biochem. Biophys. 348 (1997) 383-390
34. Wyss A., Gustafsson J.-Å., and Warner M. Cytochromes P450 of the 2D subfamily in rat brain. Mol. Pharmacol. 47 (1995) 1148-1155
35. Yu A.-M., Idle J.R., Byrd L.G., Krausz K.W., Küpfer A., and Gonzalez F.J. Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenetics 13 (2003) 173-181
36. Yue J., Miksys S., Hoffmann E., and Tyndale R.F. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course. J. Psychiatr. Neurosci. 33 (2008) 54-63